| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/08/2006 | EP1244670B1 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
| 03/08/2006 | EP1110554B1 Medicinal compositions for treating eye diseases |
| 03/08/2006 | EP1075265B1 Use of tetracyclines for treating meibomian gland disease |
| 03/08/2006 | EP1038011B1 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system |
| 03/08/2006 | EP0977568B1 Benzocycloheptathiophene compounds |
| 03/08/2006 | EP0948327B1 Antidiabetic agents |
| 03/08/2006 | CN1744891A Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of EDHF function |
| 03/08/2006 | CN1742926A Zuoci preparation for deaf and new preparing method thereof |
| 03/08/2006 | CN1742889A Qi-tonifying intelligence-promoting preparation and preparing method thereof |
| 03/08/2006 | CN1742750A Bear-gall dropping pills and preparing method |
| 03/08/2006 | CN1742727A Lomefloxacin eye gel |
| 03/08/2006 | CN1742602A Candy with components good for eyes |
| 03/08/2006 | CN1244580C Aminothiazoles and their use as adenosine receptor antagonists |
| 03/08/2006 | CN1244576C Chemical compounds |
| 03/08/2006 | CN1244338C Health care products for improving blood circulation and relieving fatigue of eye |
| 03/08/2006 | CN1244331C Fumigating tea for eye health-care |
| 03/07/2006 | US7009060 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| 03/07/2006 | US7008959 Preparing a novel crystal form by sonication and temperature oscillation of a suspension; filtered and dried faster; treating cardiovascular disorders |
| 03/07/2006 | US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient |
| 03/07/2006 | US7008927 Pralmorelin-containing nasal drop preparations |
| 03/07/2006 | US7008921 Materials and methods relating to endothelial cell growth inhibitors |
| 03/07/2006 | US7008631 Administering tetracycline antibiotics |
| 03/02/2006 | WO2006022442A1 Novel heterocyclic amide derivatives having dihydroorotate dehydrogenase inhibiting activity |
| 03/02/2006 | WO2006021418A1 2-sulfanyl-benzoimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
| 03/02/2006 | WO2003062248A3 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 03/02/2006 | DE60108394T2 Sulfonyl-pyrrolidinderivate geeignet für die behandlung von neurologischen krankheiten Sulfonyl-pyrrolidine derivatives suitable for the treatment of neurological diseases |
| 03/02/2006 | CA2578064A1 Treatment of eye disorders characterized by an elevated intraocular pressure by sirnas |
| 03/02/2006 | CA2577748A1 2-sulfanyl-benzoimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
| 03/02/2006 | CA2576552A1 Eye drops for the treatment of dry eye |
| 03/01/2006 | EP1630230A2 Streptococcus pneumoniae proteins and nucleic acids |
| 03/01/2006 | EP1629842A1 Topical application of thiazolyl amides |
| 03/01/2006 | EP1629831A2 Vitreous humor tamponade and its use |
| 03/01/2006 | EP1628678A2 Methods and compositions for treating eye disorders |
| 03/01/2006 | EP1628661A2 Modulators of vr1 receptor |
| 03/01/2006 | EP1551417A4 Three layer tear formulation |
| 03/01/2006 | EP1453523B1 Heparin-containing ophthalmic agent |
| 03/01/2006 | EP1392292B1 Pyranoindazoles and their use for the treatment of glaucoma |
| 03/01/2006 | EP1339710B1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 03/01/2006 | EP1233962B1 Novel heterocyclic compounds and their use as medicines |
| 03/01/2006 | EP1206471B1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 03/01/2006 | EP1169465B1 Two-step immunization procedure against chlamydia infection |
| 03/01/2006 | CN1741820A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/01/2006 | CN1741811A Use of ROM production and release inhibitors to treat and prevent intraocular damage |
| 03/01/2006 | CN1741803A Use of n-desmethylclozapine to treat human neuropsychiatric disease |
| 03/01/2006 | CN1740151A 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 03/01/2006 | CN1740150A 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 03/01/2006 | CN1739695A Chinese medicine for treating cataract and its prepn |
| 03/01/2006 | CN1739675A Transdermal medicine for treating cataract |
| 03/01/2006 | CN1739674A Chinese medicine for treating electric ophthalmia |
| 03/01/2006 | CN1739616A Skullcap root extract prepn for eye and its prepn process |
| 03/01/2006 | CN1739545A Pueraria flavone micro pill prepn and its prepn process |
| 03/01/2006 | CN1739541A Puerarin prepn for eye and its prepn process |
| 03/01/2006 | CN1739539A Use of puerarin in preparing medicine for treating myopia |
| 03/01/2006 | CN1739520A Sildenafil and its recipe for treating tinnitus and deafness |
| 03/01/2006 | CN1739508A Prepn process of isocollidine for eye |
| 03/01/2006 | CN1243773C Process for cross-linking hyaluronic acid to polymers |
| 03/01/2006 | CN1243753C Substituted 3,4-dihydro-pyrimido[1,2-A] pyrimidines and 3,4-dihydropyrazino [1,2-A] pyrimidines |
| 03/01/2006 | CN1243746C Heterocyclic compound inhibiting angiogenesis |
| 03/01/2006 | CN1243548C Eye drops |
| 02/28/2006 | US7005448 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma |
| 02/28/2006 | US7005442 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents |
| 02/28/2006 | US7005434 Compounds and uses thereof |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | US7005431 Imidazo-triazine derivatives as ligands for gaba receptors |
| 02/28/2006 | CA2332535C Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 02/23/2006 | WO2006020979A2 Factor vii conjugates for selectively treating neovascularization disorders |
| 02/23/2006 | WO2006018657A1 Hdac inhibitors and methods of use thereof |
| 02/23/2006 | WO2005061538A3 Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its uses for the treatment of angiogenic-related disorders |
| 02/23/2006 | US20060040984 Novel piperidine derivatives for use in the treatment of chemokine medicated disease states |
| 02/23/2006 | US20060040976 Thiobenzimidazole derivatives |
| 02/23/2006 | US20060040963 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/23/2006 | US20060040957 Bicyclic pyrimidine matrix metalloproteinase inhibitors |
| 02/23/2006 | US20060040956 Substituted alkylamine derivatives and methods of use |
| 02/23/2006 | US20060040933 Antiinflammatory agents |
| 02/23/2006 | US20060040876 Modulation of peroxisome proliferator-activated receptors |
| 02/23/2006 | US20060040853 Methods and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras |
| 02/23/2006 | US20060040312 Uses of kappa-conotoxin PVIIA |
| 02/23/2006 | US20060039979 Drug delivery system using subconjunctival depot |
| 02/23/2006 | US20060039959 Film-Shaped Mucoadhesive Administration Forms For Administering Cannabis Agents |
| 02/23/2006 | DE20023745U1 Method of modulating expression of an endogenous cellular gene in a cell to prevent gene activation or prevent repression of gene expression comprising contacting a target sequence with a zinc finger protein |
| 02/22/2006 | EP1627643A2 Vascular endothelial cell growth factor antagonists |
| 02/22/2006 | EP1627637A1 Ophthalmic solution containing quinolone antimicrobial compound |
| 02/22/2006 | EP1414812B1 Hydroxamic acid derivatives |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | EP1385856B1 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
| 02/22/2006 | EP1385839B1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/22/2006 | EP1278818B1 Use of low ionic strength ophthalmic compositions |
| 02/22/2006 | EP0957929B1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/22/2006 | CN1738817A Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same. |
| 02/22/2006 | CN1738624A Method of treatment of myocardial infarction |
| 02/22/2006 | CN1738618A Pharmaceutical compositions and their uses |
| 02/22/2006 | CN1738610A Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye |
| 02/22/2006 | CN1736474A Reversible heat gelling aquatic pharmaceutical composition of a Chinese medicine and compound prescription thereof |
| 02/22/2006 | CN1736463A Medicinal formulation for treating asthenopia and preparation process thereof |
| 02/22/2006 | CN1736462A Chinese proprietary medicine making fleece-flower root as main raw material |
| 02/22/2006 | CN1243018C Blood vessel generating inhibitor |
| 02/22/2006 | CN1242811C New use of recombinant hirudin |
| 02/22/2006 | CN1242741C Preparation and diabetic use of gibberellins |
| 02/21/2006 | US7002022 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 02/21/2006 | US7001917 2-(4-(4-(4-Fluorophenyl)-3,5-imethyl-1H-pyrazol-1-yl)phenyl) ethyl (4-methylphenyl)sulfonylcarbamate ammonium salt, e.g., as an antagonist for Prostoglandin E receptor; analgesics; antipyretics; antiinflammatory agents |